Yokota Shumpei | Department Of Pediatrics Yokohama City University School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

日本における死亡退院した児の家族への精神的サポートの検討
Soluble tumor necrosis factor receptor-I in preterm infants with chorioamnionitis
小児結核における全血インターフェロンγ応答測定法の有用性について
Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab
Comparison of markers for fetal inflammatory response syndrome : Fetal blood interleukin-6 and neonatal urinary β_2-microglobulin
Cross-cultural adaptation and validation of the Japanese version of the Childhood Health Assessment Questionnaire (CHAQ)
Methotrexate for the treatment of juvenile idiopathic arthritis : process to approval for JIA indication in Japan
Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007)
Different patterns of cytokines, ECP and immunoglobulin profiles at two adverse drug reactions in a patient
Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan
Pharmacokinetics, efficacy, and safety of short-term (12 weeks) etanercept for methotrexate-refractory polyarticular juvenile idiopathic arthritis in Japan
Transient remission of intractable systemic-type of juvenile rheumatoid arthritis after chickenpox in a 2-year-old boy
Contribution of CD4^+ or CD8^+ T cell subsets in the induction of asthma in C57BL/6 mice
The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis
Hyper-IgD syndrome with novel mutation in a Japanese girl
早産児における血中 soluble tumor necrosis factor receptor-1 の経時的変化と慢性肺疾患との関係
本邦における不明熱をきたす小児熱性疾患の全国実態調査
NICUにおける早期退院と再入院率の検討
Mizoribine : Mode of action and effects in clinical use
Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis : experience from Japanese clinical trials
Guidance on using tocilizumab for juvenile idiopathic arthritis
Acquisition of expanded indications for intravenous cyclophosphamide in the management of childhood rheumatic disease in general
De novo 19q13.42 duplications involving NLRP gene cluster in a patient with systemic-onset juvenile idiopathic arthritis
Association of HLA-A^*02:06 and HLA-DRB1^*04:05 with clinical subtypes of juvenile idiopathic arthritis

もっと見る

スポンサーリンク